Avoid common mistakes on your manuscript.
Article Corrected
Lyseng-Williamson KA. Oral bepotastine in allergic disorders. Drugs 2010; 70 (12): 1579–91
Correction Made
Page 1583: Line 7 of the second bullet point of the ‘Special Patient Populations’ subsection, which previously read:
“…moderate to severe renal impairment (creatinine clearance [CLCR] 6–70 mL/min)…”
has now been corrected as follows:
“…moderate to severe renal impairment (creatinine clearance [CLCR] 6–50 mL/min)…”
Note
All online versions of this article have been updated to reflect this correction.
Additional information
The original online version for this chapter can be found at http://dx.doi.org/10.2165/11205880-000000000-00000
Rights and permissions
About this article
Cite this article
Lyseng-Williamson, K.A. Erratum to Oral bepotastine in allergic disorders. Drugs 71, 756 (2011). https://doi.org/10.2165/11592650-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11592650-000000000-00000